Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MML Capital Partners is an international private equity firm that provides flexible growth capital to mid-market enterprises across Europe and the United States. The firm maintains a dedicated focus on the healthcare and life sciences sectors, where it partners with management teams to scale specialized service providers, clinical research organizations (CROs), and pharmaceutical outsourcing businesses. Notable investments in the healthcare space have included Viroclinics-DDL, a leading virology contract research organization, and Quay Pharma, a specialist in drug formulation and clinical trial manufacturing. MML's investment approach typically involves supporting organic growth initiatives and strategic international acquisitions to build market-leading platforms. With offices in London, Paris, New York, and Dublin, the firm manages significant capital on behalf of institutional investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MML Capital Partners.